| |
| | Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves ... (Site not responding. Last check: 2007-10-19) |
 | | The effect of EDTA, desferrioxamine (DFO), and the di-2-pyridylketone p-hydroxybenzoyl hydrazone (PKIH) analogues [PKIH, di-2-pyridylketone thiophenecarboxyl hydrazone (PKTH), di-2-pyridylketone benzoyl hydrazone (PKBH), di-2-pyridylketone m-bromobenzoyl hydrazone (PKBBH), di-2-pyridylketone p-aminobenzoyl hydrazone (PKAH), and di-2-pyridylketone p-hydroxybenzoyl hydrazone (PKHH)] on ascorbate oxidation (A) and the hydroxylation of benzoate in the presence of Fe and hydrogen peroxide (B). |
 | | The effect of doxorubicin (DOX) and the di-2-pyridylketone p-hydroxybenzoyl hydrazone (PKIH) analogues [PKIH, di-2-pyridylketone thiophenecarboxyl hydrazone (PKTH), di-2-pyridylketone benzoyl hydrazone (PKBH), di-2-pyridylketone m-bromobenzoyl hydrazone (PKBBH), di-2-pyridylketone p-aminobenzoyl hydrazone (PKAH), and di-2-pyridylketone p-hydroxybenzoyl hydrazone (PKHH)] on the proportion of precipitable DNA in SK-N-MC neuroepithelioma cells. |
 | | Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase. |
| clincancerres.aacrjournals.org /cgi/content/full/10/21/7365 (5473 words) |
|